1887

Abstract

SUMMARY

A sub-immunizing dose of a synthetic peptide corresponding to the amino acids 141 to 160 region of protein VP1 from foot-and-mouth disease virus (FMDV), serotype O, coupled to keyhole limpet haemocyanin (141-160KLH) has been shown to prime the immune system of guinea-pigs for an FMDV serotype-specific neutralizing antibody response to a second sub-immunizing dose of the same peptide. Optimal priming required an interval of 42 days between the priming dose and the booster dose. No priming was observed in the absence of adjuvant. The secondary response was not restricted by the carrier since animals primed with 141-160KLH could be boosted with uncoupled 141–160 or 141–160 coupled to tetanus toxoid. It has also been shown that uncoupled peptide 141–160 will prime for a neutralizing antibody response when it is incorporated into a relatively non-immunogenic carrier such as small unilamellar liposomes. These results indicate that the 141–160 peptide of FMDV, as well as containing an important neutralizing antibody site, can initiate its own T-helper cell response.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-66-11-2347
1985-11-01
2022-01-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/66/11/JV0660112347.html?itemId=/content/journal/jgv/10.1099/0022-1317-66-11-2347&mimeType=html&fmt=ahah

References

  1. Bachrach H. L., Moore D. M., McKercher P. D., Polatnick J. 1975; Immune and antibody responses to an isolated capsid protein of foot and mouth disease virus. Journal of Immunology 115:1635–1641
    [Google Scholar]
  2. Bittle J. L., Houghten R. A., Alexander J., Shinnick T. M., Sutcliffe J. G., Lerner R. A., Rowlands D. J., Brown F. 1982; Protection against foot and mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature, London 298:30–33
    [Google Scholar]
  3. Bittle J. L., Worrell P., Houghten R. A., Lerner R. A., Rowlands D. J., Brown F. 1984; Immunization against foot and mouth disease with a chemically synthesized peptide. In Modern Approaches to Vaccines pp 103–107 Edited by Chanock R. M., Lerner R. A. New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
  4. Brown F., Cartwright B. 1963; Purification of radioactive foot and mouth disease virus. Nature, London 199:1168–1170
    [Google Scholar]
  5. Clarke B. E., Carroll A. R., Rowlands D. J., Nicholson B. H., Houghten R. A., Lerner R. A., Brown F. 1983; Synthetic peptides mimic subtype specificity of foot and mouth disease virus. FEBS Letters 157:261–264
    [Google Scholar]
  6. Cunningham A. J., Sercarz E. E. 1971; The asynchronous development of immunological memory in helper (T) and precursor (B) cell lines. European Journal of Immunology 1:413–421
    [Google Scholar]
  7. Emini E. A., Jameson B. A., Wimmer E. 1983; Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides. Nature, London 304:699–703
    [Google Scholar]
  8. Francis M. J., Black L. 1983; Antibody response in pig nasal fluid and serum following foot and mouth disease infection or vaccination. Journal of Hygiene 91:329–334
    [Google Scholar]
  9. Francis M. J., Fry C. M., Rowlands D. J., Brown F., Bittle J. L., Houghten R. A., Lerner R. A. 1985; Priming with peptides of foot and mouth disease virus. In Vaccines 1985: pp 203–210 Edited by Lerner R. A., Chanock R., Brown F. New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
  10. Glenny A. T., Sudmersen H. J. 1921; Notes on the production of immunity to diphtheria toxin. Journal of Hygiene 20:176–220
    [Google Scholar]
  11. Kennedy R. C., Dreesman G. R. 1984; Enhancement of the immune response to hepatitis B surface antigen. Journal of Experimental Medicine 159:655–665
    [Google Scholar]
  12. Kurz C., Forss S., Kupper H., Strohmaier K., SChaller H. 1981; Nucleotide sequence and corresponding amino acid sequence of the gene for the major antigen of foot and mouth disease virus. Nucleic Acids Research 9:1919–1931
    [Google Scholar]
  13. Laporte J., Grosclaude J., Wantyghem J., Bernard S., Rouze P. 1973; Neutralization en culture cellulaire du pouvoie infectieux du virus de la fievre aphteuse par les serums provenant de pores immunisés a l’aide d’une proteine virale purifiee. Comptes rendus hebdomadaires des seances de l’Academie des sciences, série D 276:3399–3401
    [Google Scholar]
  14. Makela O., Mitchison N. A. 1965; The role of cell number and source in adoptive immunity. Immunology 8:539–548
    [Google Scholar]
  15. Mitchison N. A. 1971; The carrier effect in the secondary response to hapten protein conjugates. II. Cellular cooperation. European Journal of Immunology 1:18–27
    [Google Scholar]
  16. Nossal G. J. V., Austin C. M., Ada G. L. 1965; Antigens in immunity. VII. Analysis of immunological memory. Immunology 9:333–348
    [Google Scholar]
  17. Ovary Z., Benacerraf B. B. 1963; Immunological specificity of the secondary response with dinitrophenylated proteins. Proceedings of the Society for Experimental Biology and Medicine 114:72–76
    [Google Scholar]
  18. Palfreyman J. W., Aitcheson T. C., Taylor P. 1984; Guidelines for the production of polypeptide specific antisera using small synthetic oligopeptides as immunogens. Journal of Immunological Methods 75:383–393
    [Google Scholar]
  19. Pfaff E., Mussgay M., Bohm H. O., Schulz G. E., Schaller H. 1982; Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus. EMBO Journal 1:869–874
    [Google Scholar]
  20. Raff M. C. 1970; Role of thymus-derived lymphocytes in the secondary humoral immune response in mice. Nature, London 226:1257–1258
    [Google Scholar]
  21. Rajewsky K., Schirrmacher M., Nase S., Jerne N. K. 1969; The requirement of more than one antigenic determinant for immunogenicity. Journal of Experimental Medicine 129:1131–1143
    [Google Scholar]
  22. Rowlands D. J., Clarke B. E., Carroll A. R., Brown F., Nicholson F. B. H., Bittle J. L., Lerner R. A. 1983; Chemical basis of antigenic variation in foot and mouth disease virus. Nature, London 306:694–697
    [Google Scholar]
  23. Souhami R. L., Patel H. M., Ryman B. E. 1981; The effect of reticuloendothelial blockade on the blood clearance and tissue distribution of liposomes. Biochimica et biophysica acta 674:354–371
    [Google Scholar]
  24. Strohmaier K., Franze R., Adam K. H. 1982; Location and characterization of the antigenic portion of the FMDV immunizing protein. Journal of General Virology 59:295–306
    [Google Scholar]
  25. Voller A., Bidwell D. E. 1976; Enzyme immunoassays for antibodies in measles, cytomegalovirus infections and after rubella vaccinations. British Journal of Experimental Pathology 57:243–247
    [Google Scholar]
  26. Wild T. F., Burroughs J. N., Brown F. 1969; Surface structure of foot-and-mouth disease virus. Journal of General Virology 4:313–320
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-66-11-2347
Loading
/content/journal/jgv/10.1099/0022-1317-66-11-2347
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error